Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 25, 2012 (May 23, 2012)

 

 

Endo Health Solutions Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-15989   13-4022871

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

100 Endo Boulevard, Chadds Ford, PA   19317
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (610) 558-9800

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

  (a) At the Company’s Annual Meeting of Stockholders on May 23, 2012, the Company’s stockholders approved the proposal to amend and restate the Company’s Amended and Restated Certificate of Incorporation to change the name of the Company to Endo Health Solutions Inc. On May 23, 2012, the Company filed the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware reflecting the Company’s new name.

Also on May 23, 2012, the Company amended and restated its Amended and Restated By-laws to reflect the name change.

The foregoing descriptions of (1) the Amended and Restated Certificate of Incorporation and (2) the Amended and Restated By-laws are qualified in their entirety by reference to the full text of the Amended and Restated Certificate of Incorporation and the Amended and Restated By-laws, copies of which are attached as Exhibits 3.1 and 3.2, respectively, and are incorporated herein by reference.

On May 23, 2012, the Company issued a press release announcing the change of its name. A copy of this press release is furnished as Exhibit 99.1 to this report.

 

  (b) Not applicable.

 

  (c) Not applicable.

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

  (a) On May 23, 2012, the Company held its Annual Meeting of Stockholders.

 

  (b) Stockholders voted on the matters set forth below.

 

  1. The proposal to elect nine directors, representing all of the members of the Board of Directors of the Company, to serve until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified was approved based upon the following votes:

 

Nominee    Votes For
Approval
     Votes Against      Abstentions     

Broker

Non-Votes

 

Roger H. Kimmel

     99,998,772         870,224         36,869         5,252,212   

John J. Delucca

     100,372,107         482,850         50,908         5,252,212   

David P. Holveck

     100,393,412         478,200         34,253         5,252,212   

Nancy J. Hutson, Ph.D.

     100,389,758         481,996         34,111         5,252,212   

Michael Hyatt

     100,006,286         863,274         36,305         5,252,212   

William P. Montague

     100,385,348         485,544         34,973         5,252,212   

David B. Nash, M.D., M.B.A.

     100,306,748         549,315         49,802         5,252,212   

Joseph C. Scodari

     100,388,946         478,610         38,309         5,252,212   

William F. Spengler

     100,388,954         481,330         35,581         5,252,212   

 

  2. The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2012 was approved based upon the following votes:

 

Votes for approval

     104,668,597   

Votes against

     1,444,505   

Abstentions

     44,975   

Broker non-votes

     —     

 

  3. The proposal to approve, by advisory vote, named executive officer compensation was approved based upon the following votes:

 

Votes for approval

     88,901,511   

Votes against

     11,828,538   

Abstentions

     175,816   

Broker non-votes

     5,252,212   

 

  4. The proposal to approve the amendment and restatement to the Company’s amended and restated certificate of incorporation to change the name of the Company to Endo Health Solutions Inc. was approved based upon the following votes:

 

Votes for approval

     105,784,695   

Votes against

     62,959   

Abstentions

     310,423   

Broker non-votes

     —     

 

  5. Such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof:

None.

 

  (c) Not applicable.

 

  (d) Not applicable.


Item 9.01. Financial Statements and Exhibits.

 

  (a) Financial Statements of Business Acquired.

Not applicable.

 

  (b) Pro Forma Financial Information.

Not applicable.

 

  (c) Shell Company Transactions.

Not applicable.

 

  (d) Exhibits.

 

Exhibit
Number

  

Description

3.1    Amended and Restated Certificate of Incorporation of Endo
3.2    Amended and Restated By-laws of Endo
99.1    Press Release


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

ENDO HEALTH SOLUTIONS INC.

                    (Registrant)

By:   /s/ CAROLINE B. MANOGUE
Name:   Caroline B. Manogue
Title:  

Executive Vice President, Chief Legal Officer

& Secretary

Dated: May 25, 2012


INDEX TO EXHIBITS

 

Exhibit
Number

  

Description

3.1    Amended and Restated Certificate of Incorporation of Endo
3.2    Amended and Restated By-laws of Endo
99.1    Press Release